{"entity":{"id":"nct00003475","kind":"trial","name":"Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors","aka":[],"tldr":"A phase 2 trial of Antineoplastons in Brain and spinal cord tumours, run by Burzynski Research Institute, completed.","summary":"Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors is a phase 2 interventional study registered as NCT00003475 by Burzynski Research Institute, with 40 participants recorded, started 1996-02 and reaching its primary completion in 2011-05. Interventions recorded: Antineoplaston therapy (Atengenal + Astugenal). Conditions recorded: Malignant Brain Tumors.\n\nLinked to the technology Antineoplastons because the registry's title names it (\"antineoplastons\") and Brain and spinal cord tumours among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00003475","url":"https://clinicaltrials.gov/study/NCT00003475"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["brain-tumours"],"sections":[],"technologies":["antineoplastons"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00003475","phase":"2","setting":"Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Primary Malignant Brain Tumors","sponsor":"Burzynski Research Institute","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00003475/","neighbours":{"cancer":[{"id":"brain-tumours","kind":"cancer","name":"Brain and spinal cord tumours (all types)","route":"/cancers/brain-tumours/"}],"technology":[{"id":"antineoplastons","kind":"technology","name":"Antineoplastons (Burzynski clinic)","route":"/technologies/antineoplastons/"}]}}